Item 7.01 Regulation FD Disclosure.
On December 15, 2020, Synaptogenix, Inc. (the "Company") hosted a conference
call for purposes of providing a business update on activities of the Company. A
copy of the transcript of the conference call is attached as Exhibit 99.1 to
this Current Report on Form 8-K and is incorporated into this Item 7.01 by
The information furnished pursuant to this Item 7.01, including Exhibit 99.1
hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to
the liabilities under that Section or Sections 11 and 12(a)(2) of the Securities
Act of 1933, as amended (the "Securities Act"), and shall not be deemed to be
incorporated by reference into any filing of the Company under the Securities
Act or the Exchange Act, except as shall be expressly set forth by specific
reference in such filing.
Item 9.01 Financial Statements and Exhibits.
99.1 Script of Synaptogenix, Inc. conference call held on December 15, 2020.
© Edgar Online, source Glimpses